81. Programming Distributed Fault Tolerant Systems 14 Francisco Guerra Santana , Francisco Javier Miranda González , angel Alvarez , Sergio Arévalo, An Ada Library to Program FaultTolerant Distributed http://portal.acm.org/citation.cfm?id=269629.269632

82. Ángel González Translate this page La Biblioteca de autor dedicada al poeta ovetense Ángel González se ubica dentro de la Biblioteca Virtual Miguel de Cervantes y ofrece una amplia selección http://www.cervantesvirtual.com/bib_autor/AGonzalez/

Página mantenida por el Taller Digital Marco legal Si su navegador no soporta Javascript, puede acceder a las obras del catálogo a través de la ficha de la obra.

83. Food Mixing By Generalist Grasshoppers Plant Secondary Compounds Your browser may not have a PDF reader available. Google recommends visiting our text version of this document. http://www.springerlink.com/index/X27Q356L330861T0.pdf

84. Business & Technology | Patient In Targeted Genetics Arthritis-drug Trial Dies | By Ángel González. Seattle Times business reporter. Shortly after suspending a major clinical Ángel González 206515-5644 or agonzalez@seattletimes.com http://seattletimes.nwsource.com/html/businesstechnology/2003807982_tgen27.html

self.name = "parentSection"; The Seattle Times Company NWjobs NWautos NWhomes ... Shopping initnav('timesnav'); initnav('marketplacenav'); Advanced search Movies Restaurants Today's events Hi Contact us Friday, July 27, 2007 - Page updated at 02:04 AM E-mail article Print view Share: Digg Newsvine Patient in Targeted Genetics arthritis-drug trial dies Seattle Times business reporter Shortly after suspending a major clinical trial because of serious illness in a patient, Targeted Genetics and federal regulators said Thursday that the person had died. Whether it was the experimental arthritis drug being tested that caused the illness is not yet known. But the condition "was related in time to the receipt of a second injection of the product," the U.S. Food and Drug Administration said Thursday in a statement. The agency is investigating whether the illness was related to the treatment. The FDA said it was informed about the death of the patient on Tuesday, the same day Targeted Genetics announced the interruption of the clinical trial in the wake of an "adverse event" for a patient. "We are deeply saddened by the death of an individual enrolled in our clinical trial," Chief Executive H. Stewart Parker said Thursday in a statement.

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 5     81-84 of 84    Back | 1  | 2  | 3  | 4  | 5